Modulating transcription of genes in vascular cells

Details Modulating transcription of genes in vascular cells Modulating transcription of genes in vascular cells

2007-03-06

2007-03-06

Nguyen, Dave Trong (Department: 1632)

Chemistry: molecular biology and microbiology

Animal cell, per se ; composition thereof; process of...

Method of regulating cell metabolism or physiology

C435S455000, C435S325000, C514S04400A, C424S009100, C424S009200

Reexamination Certificate

active

10413042

ABSTRACT:
A method of modulating the transcription of one or more genes in a vascular or cardiac cell, wherein the method comprises a step of contacting the cell with a composition comprising one or more double-stranded nucleic acid(s) capable of sequence-specific binding to the transcription factor AP-1 and/or C/EBP or a related transcription factor.

REFERENCES:
patent: 5858673 (1999-01-01), Price et al.
patent: 5977334 (1999-11-01), Ransohoff et al.
patent: 6599741 (2003-07-01), Hecker et al.
patent: 29916160 (1999-09-01), None
patent: 0 733 370 (1996-09-01), None
patent: 0 856 582 (1998-08-01), None
patent: 06201692 (1994-07-01), None
patent: 07126168 (1995-05-01), None
patent: 10036272 (1998-02-01), None
patent: WO 94/20113 (1994-09-01), None
patent: WO 95/01429 (1995-01-01), None
patent: WO 95/02053 (1995-01-01), None
patent: WO 95/11684 (1995-05-01), None
patent: WO 95/11687 (1995-05-01), None
patent: WO 96/12011 (1996-04-01), None
patent: WO 98/25967 (1998-06-01), None
patent: WO 98/56806 (1998-12-01), None
patent: WO 99/00488 (1999-01-01), None
patent: WO 99/10486 (1999-03-01), None
patent: WO 99/24574 (1999-05-01), None
patent: WO 99/33999 (1999-07-01), None
Alam, “Multiple Elements Within the 5′ Distal Enhancer of the Mouse Heme Oxygenase-1 gene Mediate Induction by Heavy Metals,”Chemical Abstracts121:172189b (1994).
Beurton et al., “Delineation of the Insulin-Responsive Sequence in the Rat Cytosolic Aspartate Aminotransferase Gene: Binding Sites for Hepatocyte Nuclear Factor-3 and Nuclear Factor I,”Biochem J.343:687-695 (1999).
Chandrasekar et al., “Regulation of CCAAT/Enhancer Binding Protein, Interleukin-6, Interleukin-6 Receptor, and gp130 Expression, During Myocardial Ischemia/Reperfusion.”Chemical Abstracts130:323742r (1999).
Colangelo et al., “β-Adrenergic Receptor-Induced Activation of Nerve Growth Factor Gene Transcription in Rat Cerebral Cortex Involves CCAAT/Enhancer-Binding Protein δ,”Proc. Natl. Acad. Sci. USA95:10920-10925 (1998).
Costa et al., “Site-Directed Mutagenesis of Hepatocyte Nuclear Factor (HNF) Binding Sites in the Mouse Transthyretin (Ttr) Promoter Reveal Synergistic Interactiosn with its Enhancer Regioin,”Chemical Abstracts115:176494w (1991).
Eickelberg et al., “Transforming Growth Factor-B1 Induces Interleukin-6 Expression via Activating Protein-1 Consisting of JunD Homodimers in Primary Human Lung Fibroblasts,”Chemical Abstracts131:83453x (1999).
Frame et al., “Regulation of AP-1/DNA Complex Formation in vitro,”Chemical Abstracts114:180493s (1991).
Guyton et al., “Induction of the Mammalian Stress Response GeneGADD153by Oxidative Stress: Role of AP-1 Element,”Biochem. J.314:547-554 (1996).
Mietus-Snyder et al., “Transcriptional Activation of Scavenger Receptor Expression in Human Smooth Muscle Cells Requires AP-1/c-Jun and C/EBPB: Both AP-1 Binding and JNK Activation are Induced by Phorbol Esters and Oxidative Stress,”Chemical Abstracts130:48189y (1999).
Mukaida et al., “Novel Mechanism of Glucocorticoid-Mediated Gene Repression. Nuclear Factor-xB is Target for Glucocorticoid—Mediated Interleukin 8 Gene Repression,”Chemical Abstracts120:316132g (1994).
Nishizawa, “Leucine Zipper—A Characteristic Property of a New Category of DNA Binding Proteins,”Chemical Abstracts111:210601h (1989).
Nuthall et al., “Analysis of DNase-l-Hypersensitive Sites at the 3′ End of the Cystic Fibrosis Transmembrane Conductance Regulator Gene (CFTR),”Biochem. J.341:601-611 (1999).
Ondrey et al., “Constitutive Activation of Transcription Factors NF-xB, AP-1, and NF-IL6 in Human Head and Neck Squamous Cell Carcinoma Cell Lines that Express Pro-Inflammatory and Oro-Angiogneic Cytokines,”Chemical Abstract131:335679j (1999).
Ross et al., “A Fat-Specific Enhancer is the Primary Determinant of Gene Expression for Adipocyte P2in vivo,”Proc Natl. Acad. Sci. USA87:9590-9594 (1990).
Sabatakos et al., “Expression of the Genes Encoding CCAAT-Enhancer Binding Protein isoforms in the Mouse Mammary Gland During Lactation and Involution,”Biochem. J.334:205-210 (1998).
Samadani et al., “Identification of a Transthyretin Enhancer Site that Selectively Binds the Hepatocyte Nuclear Facctor-3B Isoform,”Chemical Abstracts126:55621d (1997).
Stauffer et al., “Characterization of Transcriptional Regulatory Elements in the Pormoter Region of Mring Blood Coagulation Factor VII Gene,”Chemical Abstracts128:201628w (1998).
Lauth et al.,European Journal of Physiologyvol. 437 Supplement; Abstract 017-2 (1999).
Wagner et al., “Transcription Factors AP-1 and C/EBP are Involved in the Expression of the Endothelin (ETa) Receptor in Vascular Smooth Muscle Cells,” Abstracts of the 78thAnnual Meeting, Deutsche Physiologische Gesellschaft, Mar. 14, 1999.
Miller et al., “Targeted Vectors for Gene Therapy,”FASEB J.9:190-199 (1995).
Deonarain, “Ligand-Targeted Receptor Mediated Vectors for Gene Delivery,”Exp. Opin. Ther. Parents8:53-69 (1998).
Verma et al., “Gene Therapy-Promises, Problems, and Prospects,”Nature389:239-242 (1998).
Crystal, “Transfer of Genes to Humans: Early Lessons and Obstacles to Success,”Science270:404-410 (1995).
Morishita et al., “Oligonucleonucleotide-Based Gene Therapy for Cardiovascular Disease,”Clin. Chem. Lab Med.36:529-534 (1998).
Penning, “Hydroxyusteroid Dehydrogenase: Three Dimensional Structure and Gene Regulation,”Journal of Endocrinology150:S175-S187 (1996).
Salvatore et al., “The Guanosine Monophosphate Reductase Gene is Conserved in Rats and Its Expression . . . Tissue During Cold Exposure,”The Journal of Biological Chemistry273:31092-31096 (1998).
Morishita et al., “Role of AP-1 Complex in Angiotensin 11-Mediated Transforming Growth.. Using Decoy Approach Against AP-1 Binding Site,”Bio. Research Comm.243:361-367 (1998).
Uhlmann et al., “Studies on the Mechanisms of Stabilization of Partially Phosphorothioated Oligonucleotides Against Nucleolytic Degradation,”Nucleic Acid Drug Development7:345-350 (1997).
Mann et al., “Therapeutic Applications of Transcription Factor Decoy Oligonucleotides,”Journal of Clin. Invest.106:1071-1075 (2000).
Redenti et al., “Cyclodextrins in Oligonucleotide Delivery,” Adv. Drug. Del. Rev. 53:235-244 (2001).
Nishikawa et al., “Nonviral Vector in the New Millennium: Delivery Barriers in Gene Transfer,”Human Gene Therapy12:861-870 (2001).

Affiliated with

Also associated with

Rating

Modulating transcription of genes in vascular cells does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Modulating transcription of genes in vascular cells, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modulating transcription of genes in vascular cells will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3737735